학술논문
Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase 3 study TROPION-Lung01. (German)
Document Type
Article
Author
Source
Pneumologie; 2024 Supplement 1, Vol. 78, pS99-S99, 1p
Subject
Language
German
ISSN
09348387